Recombinant WT1 antibody
Quick Overview for Recombinant WT1 antibody (ABIN6383831)
Target
See all WT1 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
- 
    
- 
                                            
Purpose
 - WT1
 - 
                                            
Purification
 - By Protein A from bioreactor concentrate
 - 
                                            
Immunogen
 - Recombinant human full-length WT1 protein
 - 
                                            
Isotype
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
Comment
 - 
                        
K562, Wilm's Tumor, mesothelioma, fetal kidney, kidney and a subset of hematopoietic cells.
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Concentration
 - 1 mg/mL
 - 
                                            
Buffer
 - 1 mg IgG/mL in PBS, 0.05 % azide
 - 
                                            
Handling Advice
 - Avoid repeated freeze/thaw cycles.
 - 
                                            
Storage Comment
 - For long term storage, keep small aliquots at -20°C or -80°C and keep one aliquot at 4°C for daily experimentations. Azide will preserve antibody at 4°C for 6-12 months, when kept away from direct sun light.
 
 - 
                                            
 - 
    
- WT1 (Wilms Tumor 1 (WT1))
 - 
                                            
Alternative Name
 - WT1
 - 
                                            
Background
 - Wilms tumor 1, AWT1, GUD, NPHS4, WAGR, WIT-2, WT33, Wilms' tumor 1
 - 
                                            
Gene ID
 - 7490
 - 
                                            
UniProt
 - P19544
 - 
                                            
Pathways
 - Tube Formation
 
Target
 -